US drug approvals
17 approvals with a product on the US market
- Maraviroc ANDA216143 · approved 4 Nov 2025
- Scopolamine ANDA215329 · approved 6 May 2024
- Lisdexamfetamine Dimesylate ANDA215330 · approved 25 Aug 2023
- Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate ANDA213111 · approved 13 Jan 2021
- Buprenorphine Hydrochloride And Naloxone Hydrochloride ANDA205601 · approved 30 Mar 2020
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
